Ophthalmology Department 1
1. Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
2. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries
3. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries
4. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries
5. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries
6. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries
7. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries
8. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries
9. Retinoblastoma outcomes in Europe: a prospective analysis of 483 patients from 40 countries
10. Immunomodulation of the Ocular Surface in Severe Dry Eye Disease: Expert-Driven Literature Review on Treatment Strategies with Description of Representative Challenging Cases
11. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
12. Clinical and economic impacts of optical coherence tomography prior to cataract surgery in a low-to-middle-income country
13. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries
14. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries
15. Retinoblastoma in Asia: Clinical Presentation and Treatment Outcomes in 2112 Patients from 33 Countries
16. Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
17. Tracking development assistance for health and for COVID-19: a review of development assistance, government, out-of-pocket, and other private spending on health for 204 countries and territories, 1990–2050
18. TOXIC EFFECTS OF CHEMOTHERAPY ON THE VISUAL ORGAN IN MALIGNANT NEOPLASMS: A SYSTEMATIC REVIEW
19. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
20. Global mortality from dementia: Application of a newmethod and results from the global burden of disease study 2019
21. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
22. Global, regional, and national burden of chronic respiratory diseases and impact of the COVID-19 pandemic, 1990–2023: a Global Burden of Disease study
23. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
24. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
25. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021
26. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
27. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
28. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
29. Global estimates on the number of people blind or visually impaired by cataract: a meta-analysis from 2000 to 2020
30. Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
31. Global burden of lower respiratory infections and aetiologies, 1990–2023: a systematic analysis for the Global Burden of Disease Study 2023
32. Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023
33. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021
34. The global burden of cancer attributable to risk factors, 2010–19: a systematic analysis for the Global Burden of Disease Study 2019
35. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
36. Global, regional, and national incidence of six major immune-mediated inflammatory diseases: findings from the global burden of disease study 2019
1